Researchers Submit Patent Application, "Proteins and nucleic acids useful in vaccines targeting Pseudomonas aeruginosa", for Approval (USPTO 20240317817).

A patent application has been submitted for proteins and nucleic acids that could be used in vaccines targeting Pseudomonas aeruginosa, a gram-negative pathogen that causes hospital-acquired infections. The inventors have identified several surface-exposed proteins of Pseudomonas aeruginosa that could be potential vaccine targets. The invention includes polypeptides, nucleic acid fragments, vectors, and transformed cells related to these proteins, as well as methods for inducing immunity and treating infections. This research aims to improve vaccination and treatment methods for Pseudomonas aeruginosa infections, which are a significant concern in healthcare settings. [Extracted from the article]